Author details

Full Name

Samantha Sartori

Affiliation

ORCID

Career Start Year

2001

Papers

228

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36660810	Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes.		2023
36270496	The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.	International Journal of Cardiology	2023
37923124	Prognostic impact of pre-frailty and frailty in women undergoing TAVR: Insights from the WIN-TAVI Registry.		2023
37742213	Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry.		2023
37587580	Bleeding and Ischemic Risks of TicagrelorÂ Monotherapy After CoronaryÂ Interventions.	J Am Coll Cardiol	2023
37734299	Gender-Based Differences in Outcomes After Percutaneous Coronary Intervention of Chronic Total Occlusions (Insights from a Large Single-Center Registry).		2023
37909222	Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry.		2023
37806185	Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial.	Am J Cardiol	2023
37804290	1- or 3-Month DAPT in Patients With HBRÂ With or Without Oral Anticoagulant Therapy After PCI.	JACC Cardiovasc Interv	2023
37879803	Dyspnea-Related Ticagrelor Discontinuation After PercutaneousÂ Coronary Intervention.	JACC Cardiovasc Interv	2023
37870970	Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: an Individual Patient Data Meta-analysis of TWILIGHT and TICO Randomized Trials.		2023
37866281	Outcomes After Complex PCI With COMBO Stent Implantation: Insights from a Real-World Pooled Dataset.		2023
37094668	Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registry.		2023
36649694	Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial.	Eur Heart J Cardiovasc Pharmacother	2023
37080466	Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT.	Int J Cardiol	2023
37459570	Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study.	Eur Heart J Acute Cardiovasc Care	2023
37393727	Impact of Clinical Presentation on Outcomes After Rotational Atherectomy in Patients Who Underwent Percutaneous Coronary Intervention.		2023
36493579	New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary Intervention.		2023
36564015	Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis.		2023
36697136	Revascularization Strategies for PatientsÂ With Femoropopliteal PeripheralÂ Artery Disease.		2023
37382924	Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI.		2023
36624012	Determinants of Seattle Angina Questionnaire in Multivessel Disease Patients Undergoing Percutaneous Coronary Intervention: Insights from a Single-Center Study.		2023
37380247	Timing and Predictors of Myocardial Infarction or Stent Thrombosis in High-Bleeding Risk Patients Undergoing PCI.		2023
37187289	Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention.		2023
36691863	Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.		2023
37042253	Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction.		2023
36989603	Trends in Vascular Access Site Use and Outcomes in Patients Undergoing PCI.		2023
37354778	Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries).		2023
37164597	Validation of UK-BCIS CHIP Score to Predict 1-Year Outcomes in a Contemporary United StatesÂ Population.		2023
36848691	Outcomes in Patients With Early Menopause Who Underwent Transcatheter Aortic Valve Implantation.		2023
36455701	Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.	International Journal of Cardiology	2023
37036268	Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.		2023
31270529	Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.	European Heart Journal	2022
35656720	Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry.	EuroIntervention	2022
35461697	Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry).	American Journal of Cardiology	2022
36040717	Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial.	Catheterization and Cardiovascular Interventions	2022
35389474	Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCI.	Eur Heart J Cardiovasc Pharmacother	2022
35934563	Outcomes After Transcatheter Aortic Valve Implantation in Men Versus Women.	American Journal of Cardiology	2022
36202563	Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index.	JACC Cardiovasc Interv	2022
35979636	Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study.	EuroIntervention	2022
35351288	Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation.	American Journal of Cardiology	2022
36423970	Ticagrelor vs Prasugrel in a Contemporary Real-World CohortÂ Undergoing Percutaneous Coronary Intervention.	JACC: Cardiovascular Interventions	2022
36384656	Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis.	Cardiovascular Diabetology	2022
35716933	Predictors of antiplatelet cessation in a real-world patient population undergoing non-cardiac surgery after PCI.	International Journal of Cardiology	2022
34274283	Pulmonary Artery F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of PulmonaryÂ Hypertension in Sarcoidosis.	JACC: Cardiovascular Imaging	2022
34142118	Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials.	Eur Heart J Cardiovasc Pharmacother	2022
34347202	Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction.	Journal of Thrombosis and Thrombolysis	2022
35317615	Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy.	Circ Cardiovasc Interv	2022
34459481	Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis.	European Heart Journal - Cardiovascular Pharmacotherapy	2022
35033468	Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy.	JACC Cardiovasc Interv	2022